Skip to content

Therapeutic Innovation Australia (TIA) – Pipeline Accelerator 2022-23

Home / Funding Opportunity / Therapeutic Innovation Australia (TIA) – Pipeline Accelerator 2022-23

Therapeutic Innovation Australia (TIA) – Pipeline Accelerator 2022-23

twitterlinkedin

The TIA Pipeline Accelerator scheme facilitates access to one or more TIA facilities to reduce the cost of access to access to a specific capability for therapeutic development projects.
  • up 50% of the cost of access to a maximum of $50,000
  • available to universities; PFROs; university or MRI tech transfer offices or spin-outs; commercial entities eligible for the R&D tax incentive
  • ECRs and female applicants strongly encouraged as lead applicant
  • capabilities available include biologics; cell & gene therapies; small molecule therapeutics; high throughput screening; in vitro genome engineering & disease modelling; biobanking & in vivo genome engineering & disease modelling; pathology
 – Applications close 28 April, download Pipeline Accelerator Guidelines 2022-23 Round 2_final

You may be also interested in ...